Viking Therapeutics: Too Much Excitement Around Oral VK2735, Even If It Met High Expectations
Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...
Viking Therapeutics' weight-loss pill shows 'great outcome' in trial
Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The news sent the stock sharply ...
MarketWatch21h
S&P 500 Information Technology Sector Index
IPC Indice de Precios Y Cotizaciones 50,882.54 260.15 0.51% ...
MarketWatch22h
S&P 500 Equal Weight Index
IPC Indice de Precios Y Cotizaciones 50,622.39-38.66-0.08% ...